Patent · US Active

Method of assaying an individual for immune impairment

US10119959B2 · kind B2 · utility

1Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 25, 2011
Grant dateNov 6, 2018
Priority date
Expiry dateJan 10, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/60
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Embodiments of the present invention provide diagnostic markers of immunosenescence and methods of identifying individuals with impaired immune function based on a combination of such markers obtained from various analyzes, primarily from blood, testing immune function including the analysis of immune cell subset frequencies, gene expression, cytokine and chemokine levels, and signaling responses to stimulation with cytokines (‘cytokine response’). Particular combinations of markers can predict with high accuracy whether an individual will respond to active vaccination and become protected against recurring diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.